The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
Y
Y
Miura
K
K
Yamada
M
M
Nakayama
H
H
Nakano
S
S
Suzuki
H
H
Tsuchida
S
S
Yoshida
D000328:Adult; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D010880:Piperidines / Q000494:pharmacology*; D015363:Quinolones / Q000494:pharmacology*
D065092:Antidiuretic Hormone Receptor Antagonists; D010880:Piperidines; D015363:Quinolones; D001127:Arginine Vasopressin; C068644:OPC 21268